 | • レポートコード：MRC2-11QY08381 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は点眼液のグローバル市場について調査・分析したレポートです。種類別（処方薬、OTC薬）市場規模、用途別（炎症・感染症、倦怠感、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別点眼液の競争状況、市場シェア ・世界の点眼液市場：種類別市場規模 2015年-2020年（処方薬、OTC薬） ・世界の点眼液市場：種類別市場規模予測 2021年-2026年（処方薬、OTC薬） ・世界の点眼液市場：用途別市場規模 2015年-2020年（炎症・感染症、倦怠感、その他） ・世界の点眼液市場：用途別市場規模予測 2021年-2026年（炎症・感染症、倦怠感、その他） ・北米の点眼液市場分析：米国、カナダ ・ヨーロッパの点眼液市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの点眼液市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の点眼液市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの点眼液市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Senju Pharmaceutical、Allergan、Novartis、Pfizer、Merck、Genentech、Teva ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ophthalmic Solution Market
The global Ophthalmic Solution market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ophthalmic Solution Scope and Market Size
Ophthalmic Solution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ophthalmic Solution market is segmented into
Prescription Drugs
OTC Drugs
Segment by Application, the Ophthalmic Solution market is segmented into
Inflammation/Infection
Relieve Fatigue
Others
Regional and Country-level Analysis
The Ophthalmic Solution market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmic Solution market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ophthalmic Solution Market Share Analysis
Ophthalmic Solution market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmic Solution business, the date to enter into the Ophthalmic Solution market, Ophthalmic Solution product introduction, recent developments, etc.
The major vendors covered:
Senju Pharmaceutical
Allergan
Novartis
Pfizer
Merck
Genentech
Teva
…
1 Study Coverage
1.1 Ophthalmic Solution Product Introduction
1.2 Market Segments
1.3 Key Ophthalmic Solution Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmic Solution Market Size Growth Rate by Type
1.4.2 Prescription Drugs
1.4.3 OTC Drugs
1.5 Market by Application
1.5.1 Global Ophthalmic Solution Market Size Growth Rate by Application
1.5.2 Inflammation/Infection
1.5.3 Relieve Fatigue
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Solution Market Size, Estimates and Forecasts
2.1.1 Global Ophthalmic Solution Revenue 2015-2026
2.1.2 Global Ophthalmic Solution Sales 2015-2026
2.2 Global Ophthalmic Solution, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ophthalmic Solution Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ophthalmic Solution Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ophthalmic Solution Competitor Landscape by Players
3.1 Ophthalmic Solution Sales by Manufacturers
3.1.1 Ophthalmic Solution Sales by Manufacturers (2015-2020)
3.1.2 Ophthalmic Solution Sales Market Share by Manufacturers (2015-2020)
3.2 Ophthalmic Solution Revenue by Manufacturers
3.2.1 Ophthalmic Solution Revenue by Manufacturers (2015-2020)
3.2.2 Ophthalmic Solution Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmic Solution Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmic Solution Revenue in 2019
3.2.5 Global Ophthalmic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ophthalmic Solution Price by Manufacturers
3.4 Ophthalmic Solution Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmic Solution Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmic Solution Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmic Solution Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ophthalmic Solution Market Size by Type (2015-2020)
4.1.1 Global Ophthalmic Solution Sales by Type (2015-2020)
4.1.2 Global Ophthalmic Solution Revenue by Type (2015-2020)
4.1.3 Ophthalmic Solution Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmic Solution Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmic Solution Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmic Solution Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmic Solution Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmic Solution Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ophthalmic Solution Market Size by Application (2015-2020)
5.1.1 Global Ophthalmic Solution Sales by Application (2015-2020)
5.1.2 Global Ophthalmic Solution Revenue by Application (2015-2020)
5.1.3 Ophthalmic Solution Price by Application (2015-2020)
5.2 Ophthalmic Solution Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmic Solution Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmic Solution Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmic Solution Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ophthalmic Solution by Country
6.1.1 North America Ophthalmic Solution Sales by Country
6.1.2 North America Ophthalmic Solution Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ophthalmic Solution Market Facts & Figures by Type
6.3 North America Ophthalmic Solution Market Facts & Figures by Application
7 Europe
7.1 Europe Ophthalmic Solution by Country
7.1.1 Europe Ophthalmic Solution Sales by Country
7.1.2 Europe Ophthalmic Solution Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmic Solution Market Facts & Figures by Type
7.3 Europe Ophthalmic Solution Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Solution by Region
8.1.1 Asia Pacific Ophthalmic Solution Sales by Region
8.1.2 Asia Pacific Ophthalmic Solution Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ophthalmic Solution Market Facts & Figures by Type
8.3 Asia Pacific Ophthalmic Solution Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ophthalmic Solution by Country
9.1.1 Latin America Ophthalmic Solution Sales by Country
9.1.2 Latin America Ophthalmic Solution Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ophthalmic Solution Market Facts & Figures by Type
9.3 Central & South America Ophthalmic Solution Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Solution by Country
10.1.1 Middle East and Africa Ophthalmic Solution Sales by Country
10.1.2 Middle East and Africa Ophthalmic Solution Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Ophthalmic Solution Market Facts & Figures by Type
10.3 Middle East and Africa Ophthalmic Solution Market Facts & Figures by Application
11 Company Profiles
11.1 Senju Pharmaceutical
11.1.1 Senju Pharmaceutical Corporation Information
11.1.2 Senju Pharmaceutical Description and Business Overview
11.1.3 Senju Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Senju Pharmaceutical Ophthalmic Solution Products Offered
11.1.5 Senju Pharmaceutical Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Ophthalmic Solution Products Offered
11.2.5 Allergan Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Ophthalmic Solution Products Offered
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Ophthalmic Solution Products Offered
11.4.5 Pfizer Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Ophthalmic Solution Products Offered
11.5.5 Merck Related Developments
11.6 Genentech
11.6.1 Genentech Corporation Information
11.6.2 Genentech Description and Business Overview
11.6.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genentech Ophthalmic Solution Products Offered
11.6.5 Genentech Related Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Description and Business Overview
11.7.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Ophthalmic Solution Products Offered
11.7.5 Teva Related Developments
11.1 Senju Pharmaceutical
11.1.1 Senju Pharmaceutical Corporation Information
11.1.2 Senju Pharmaceutical Description and Business Overview
11.1.3 Senju Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Senju Pharmaceutical Ophthalmic Solution Products Offered
11.1.5 Senju Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ophthalmic Solution Market Estimates and Projections by Region
12.1.1 Global Ophthalmic Solution Sales Forecast by Regions 2021-2026
12.1.2 Global Ophthalmic Solution Revenue Forecast by Regions 2021-2026
12.2 North America Ophthalmic Solution Market Size Forecast (2021-2026)
12.2.1 North America: Ophthalmic Solution Sales Forecast (2021-2026)
12.2.2 North America: Ophthalmic Solution Revenue Forecast (2021-2026)
12.2.3 North America: Ophthalmic Solution Market Size Forecast by Country (2021-2026)
12.3 Europe Ophthalmic Solution Market Size Forecast (2021-2026)
12.3.1 Europe: Ophthalmic Solution Sales Forecast (2021-2026)
12.3.2 Europe: Ophthalmic Solution Revenue Forecast (2021-2026)
12.3.3 Europe: Ophthalmic Solution Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ophthalmic Solution Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ophthalmic Solution Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ophthalmic Solution Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ophthalmic Solution Market Size Forecast by Region (2021-2026)
12.5 Latin America Ophthalmic Solution Market Size Forecast (2021-2026)
12.5.1 Latin America: Ophthalmic Solution Sales Forecast (2021-2026)
12.5.2 Latin America: Ophthalmic Solution Revenue Forecast (2021-2026)
12.5.3 Latin America: Ophthalmic Solution Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ophthalmic Solution Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ophthalmic Solution Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ophthalmic Solution Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ophthalmic Solution Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmic Solution Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmic Solution Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ophthalmic Solution Market Segments
Table 2. Ranking of Global Top Ophthalmic Solution Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ophthalmic Solution Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription Drugs
Table 5. Major Manufacturers of OTC Drugs
Table 6. Global Ophthalmic Solution Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Ophthalmic Solution Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Ophthalmic Solution Sales by Regions 2015-2020 (K Units)
Table 9. Global Ophthalmic Solution Sales Market Share by Regions (2015-2020)
Table 10. Global Ophthalmic Solution Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Ophthalmic Solution Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Ophthalmic Solution Sales Share by Manufacturers (2015-2020)
Table 13. Global Ophthalmic Solution Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Ophthalmic Solution by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Solution as of 2019)
Table 15. Ophthalmic Solution Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Ophthalmic Solution Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Ophthalmic Solution Price (2015-2020) (US$/Unit)
Table 18. Ophthalmic Solution Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Ophthalmic Solution Product Type
Table 20. Date of International Manufacturers Enter into Ophthalmic Solution Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 23. Global Ophthalmic Solution Sales Share by Type (2015-2020)
Table 24. Global Ophthalmic Solution Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Ophthalmic Solution Revenue Share by Type (2015-2020)
Table 26. Ophthalmic Solution Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 27. Global Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 28. Global Ophthalmic Solution Sales Share by Application (2015-2020)
Table 29. North America Ophthalmic Solution Sales by Country (2015-2020) (K Units)
Table 30. North America Ophthalmic Solution Sales Market Share by Country (2015-2020)
Table 31. North America Ophthalmic Solution Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Ophthalmic Solution Revenue Market Share by Country (2015-2020)
Table 33. North America Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 34. North America Ophthalmic Solution Sales Market Share by Type (2015-2020)
Table 35. North America Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 36. North America Ophthalmic Solution Sales Market Share by Application (2015-2020)
Table 37. Europe Ophthalmic Solution Sales by Country (2015-2020) (K Units)
Table 38. Europe Ophthalmic Solution Sales Market Share by Country (2015-2020)
Table 39. Europe Ophthalmic Solution Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Ophthalmic Solution Revenue Market Share by Country (2015-2020)
Table 41. Europe Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 42. Europe Ophthalmic Solution Sales Market Share by Type (2015-2020)
Table 43. Europe Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 44. Europe Ophthalmic Solution Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Ophthalmic Solution Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Ophthalmic Solution Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Ophthalmic Solution Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Ophthalmic Solution Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Ophthalmic Solution Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Ophthalmic Solution Sales Market Share by Application (2015-2020)
Table 53. Latin America Ophthalmic Solution Sales by Country (2015-2020) (K Units)
Table 54. Latin America Ophthalmic Solution Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Ophthalmic Solution Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Ophthalmic Solution Revenue Market Share by Country (2015-2020)
Table 57. Latin America Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 58. Latin America Ophthalmic Solution Sales Market Share by Type (2015-2020)
Table 59. Latin America Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 60. Latin America Ophthalmic Solution Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Ophthalmic Solution Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Ophthalmic Solution Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Ophthalmic Solution Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Ophthalmic Solution Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Ophthalmic Solution Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Ophthalmic Solution Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Ophthalmic Solution Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Ophthalmic Solution Sales Market Share by Application (2015-2020)
Table 69. Senju Pharmaceutical Corporation Information
Table 70. Senju Pharmaceutical Description and Major Businesses
Table 71. Senju Pharmaceutical Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. Senju Pharmaceutical Product
Table 73. Senju Pharmaceutical Recent Development
Table 74. Allergan Corporation Information
Table 75. Allergan Description and Major Businesses
Table 76. Allergan Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Allergan Product
Table 78. Allergan Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Merck Corporation Information
Table 90. Merck Description and Major Businesses
Table 91. Merck Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. Merck Product
Table 93. Merck Recent Development
Table 94. Genentech Corporation Information
Table 95. Genentech Description and Major Businesses
Table 96. Genentech Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Genentech Product
Table 98. Genentech Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Major Businesses
Table 101. Teva Ophthalmic Solution Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Global Ophthalmic Solution Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Ophthalmic Solution Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Ophthalmic Solution Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Ophthalmic Solution Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Ophthalmic Solution Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Ophthalmic Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Ophthalmic Solution Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Ophthalmic Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Ophthalmic Solution Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Ophthalmic Solution Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Ophthalmic Solution Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Ophthalmic Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Ophthalmic Solution Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Ophthalmic Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Ophthalmic Solution Players
Table 122. Ophthalmic Solution Customers List
Table 123. Ophthalmic Solution Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Solution Product Picture
Figure 2. Global Ophthalmic Solution Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription Drugs Product Picture
Figure 4. OTC Drugs Product Picture
Figure 5. Global Ophthalmic Solution Sales Market Share by Application in 2020 & 2026
Figure 6. Inflammation/Infection
Figure 7. Relieve Fatigue
Figure 8. Others
Figure 9. Ophthalmic Solution Report Years Considered
Figure 10. Global Ophthalmic Solution Market Size 2015-2026 (US$ Million)
Figure 11. Global Ophthalmic Solution Sales 2015-2026 (K Units)
Figure 12. Global Ophthalmic Solution Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Ophthalmic Solution Sales Market Share by Region (2015-2020)
Figure 14. Global Ophthalmic Solution Sales Market Share by Region in 2019
Figure 15. Global Ophthalmic Solution Revenue Market Share by Region (2015-2020)
Figure 16. Global Ophthalmic Solution Revenue Market Share by Region in 2019
Figure 17. Global Ophthalmic Solution Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Ophthalmic Solution Revenue in 2019
Figure 19. Ophthalmic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Ophthalmic Solution Sales Market Share by Type (2015-2020)
Figure 21. Global Ophthalmic Solution Sales Market Share by Type in 2019
Figure 22. Global Ophthalmic Solution Revenue Market Share by Type (2015-2020)
Figure 23. Global Ophthalmic Solution Revenue Market Share by Type in 2019
Figure 24. Global Ophthalmic Solution Market Share by Price Range (2015-2020)
Figure 25. Global Ophthalmic Solution Sales Market Share by Application (2015-2020)
Figure 26. Global Ophthalmic Solution Sales Market Share by Application in 2019
Figure 27. Global Ophthalmic Solution Revenue Market Share by Application (2015-2020)
Figure 28. Global Ophthalmic Solution Revenue Market Share by Application in 2019
Figure 29. North America Ophthalmic Solution Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Ophthalmic Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Ophthalmic Solution Sales Market Share by Country in 2019
Figure 32. North America Ophthalmic Solution Revenue Market Share by Country in 2019
Figure 33. U.S. Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Ophthalmic Solution Market Share by Type in 2019
Figure 38. North America Ophthalmic Solution Market Share by Application in 2019
Figure 39. Europe Ophthalmic Solution Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Ophthalmic Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Ophthalmic Solution Sales Market Share by Country in 2019
Figure 42. Europe Ophthalmic Solution Revenue Market Share by Country in 2019
Figure 43. Germany Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Ophthalmic Solution Market Share by Type in 2019
Figure 54. Europe Ophthalmic Solution Market Share by Application in 2019
Figure 55. Asia Pacific Ophthalmic Solution Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Ophthalmic Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Ophthalmic Solution Sales Market Share by Region in 2019
Figure 58. Asia Pacific Ophthalmic Solution Revenue Market Share by Region in 2019
Figure 59. China Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Ophthalmic Solution Market Share by Type in 2019
Figure 82. Asia Pacific Ophthalmic Solution Market Share by Application in 2019
Figure 83. Latin America Ophthalmic Solution Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Ophthalmic Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Ophthalmic Solution Sales Market Share by Country in 2019
Figure 86. Latin America Ophthalmic Solution Revenue Market Share by Country in 2019
Figure 87. Mexico Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Ophthalmic Solution Market Share by Type in 2019
Figure 94. Latin America Ophthalmic Solution Market Share by Application in 2019
Figure 95. Middle East and Africa Ophthalmic Solution Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Ophthalmic Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Ophthalmic Solution Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Ophthalmic Solution Revenue Market Share by Country in 2019
Figure 99. Turkey Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Ophthalmic Solution Sales Growth Rate (2015-2020) (K Units)
Figure 104. UAE Ophthalmic Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Ophthalmic Solution Market Share by Type in 2019
Figure 106. Middle East and Africa Ophthalmic Solution Market Share by Application in 2019
Figure 107. North America Ophthalmic Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Ophthalmic Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Ophthalmic Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Ophthalmic Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Ophthalmic Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Ophthalmic Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Ophthalmic Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Ophthalmic Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Ophthalmic Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Ophthalmic Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…- 眼科用医薬品の世界市場（～2026年） Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disor…
- 眼科用診断機器の世界市場（～2026年） Ophthalmic devices are medical devices used to identify ocular defects or deficiencies and treat eye disorders. As a result of the constant advancements in ophthalmic technology for effective treatment of eye diseases and restoration of vision, increasing number of people are opting for ophthalmic s…
- 単回使用眼科手術装置の世界市場（～2026年） Single use ophthalmic surgical devices are the products that are used only once in the process of surgery and cannot be reused again. The global single use ophthalmic surgical devices market is expected to witness a high growth in developed countries owing to better healthcare infrastructure and gro…
- 眼科用レーザーの世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Lasers Market The global Ophthalmic Lasers market size is projected to reach US$ 1008.3 million by 2026, from US$ 970.6 million in 2020, at a CAGR of 3.6%% during 2021-2026. Global Ophthalmic Lasers Scope and Market Size Ophthalmic Lasers market is seg…